- Home
- ALAR vs NSPR Comparison
ALAR vs NSPR Comparison
Compare ALAR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- NSPR
- Stock Information
- Founded
- ALAR 2013
- NSPR 2005
- Country
- ALAR Israel
- NSPR United States
- Employees
- ALAR N/A
- NSPR N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- NSPR Medical/Dental Instruments
- Sector
- ALAR Technology
- NSPR Health Care
- Exchange
- ALAR Nasdaq
- NSPR Nasdaq
- Market Cap
- ALAR 45.3M
- NSPR 75.1M
- IPO Year
- ALAR 2018
- NSPR N/A
- Fundamental
- Price
- ALAR $13.29
- NSPR $2.23
- Analyst Decision
- ALAR Strong Buy
- NSPR Strong Buy
- Analyst Count
- ALAR 1
- NSPR 2
- Target Price
- ALAR $15.00
- NSPR $4.50
- AVG Volume (30 Days)
- ALAR 263.2K
- NSPR 362.5K
- Earning Date
- ALAR 08-25-2025
- NSPR 08-05-2025
- Dividend Yield
- ALAR N/A
- NSPR N/A
- EPS Growth
- ALAR N/A
- NSPR N/A
- EPS
- ALAR 0.07
- NSPR N/A
- Revenue
- ALAR $30,581,000.00
- NSPR $7,027,000.00
- Revenue This Year
- ALAR N/A
- NSPR $4.85
- Revenue Next Year
- ALAR $12.28
- NSPR $113.47
- P/E Ratio
- ALAR $19.62
- NSPR N/A
- Revenue Growth
- ALAR 4.67
- NSPR 8.49
- 52 Week Low
- ALAR $5.45
- NSPR $1.99
- 52 Week High
- ALAR $46.69
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- ALAR 67.54
- NSPR 39.08
- Support Level
- ALAR $12.76
- NSPR $1.99
- Resistance Level
- ALAR $13.65
- NSPR $2.33
- Average True Range (ATR)
- ALAR 0.96
- NSPR 0.16
- MACD
- ALAR 0.07
- NSPR -0.02
- Stochastic Oscillator
- ALAR 71.68
- NSPR 40.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.